Early Parkinson’s Disease Detection System
Project Overview

Early Parkinson’s Disease Detection System is an AI-powered platform designed to spot the subtle motor signs of Parkinson’s disease at its earliest stages. This project uses computer vision to analyze video footage of a person’s movements – such as slight hand tremors or changes in posture – and provides an early warning of Parkinsonian indicators. By leveraging cutting-edge pose estimation and machine learning, the system offers a non-invasive, quick screening tool that could revolutionize early intervention in Parkinson’s care. It aims to empower clinicians and individuals with a reliable way to detect early symptoms before they escalate, potentially improving patient outcomes through timely treatment.

Why It Matters: Parkinson’s disease often goes undiagnosed until significant symptoms develop, by which time valuable treatment time has been lost. Our system addresses this gap by detecting minute tremors and movement patterns that are invisible to the naked eye, using just a standard camera (no specialized hardware needed). The result is a novel approach to Parkinson’s detection – fast, accessible, and easily deployable – that could supplement clinical evaluations and reach populations lacking specialized healthcare access. In short, this project demonstrates how AI and vision technology can provide a first-of-its-kind early warning system for a disease affecting millions worldwide.

Key Features

AI-Powered Tremor Detection: Utilizes state-of-the-art pose estimation algorithms to track body and hand movements in real time, capturing even millimeter-scale tremors from ordinary video. The AI isolates Parkinson’s-characteristic tremors from normal motion with high sensitivity.

Early Intervention Focus: Specifically tuned to recognize early-stage indicators – the system can flag subtle movement irregularities (like a 4–6 Hz resting tremor in a hand) that typically appear in Stage I Parkinson’s, enabling intervention sooner than traditional diagnosis.

Non-Invasive & Accessible: Requires only a standard webcam or smartphone camera to perform detection – no wearable sensors, lab tests, or invasive procedures. This makes screenings convenient and repeatable anywhere (e.g. at home or in a clinic) with minimal setup.

Real-Time Analysis & Feedback: Processes video feed in real time, providing immediate feedback. Users and clinicians can see on-screen highlights of tremor activity and receive a risk assessment within seconds of a short movement test.

User-Friendly Interface: Designed with an intuitive dashboard that visualizes the results – e.g. graphs of tremor intensity over time, and a clear “risk score” or alert if signs of Parkinson’s are detected. (See Demo Videos and Screenshots below for illustrations.)

Scalable, Modular Architecture: The system’s pipeline (pose estimation → signal processing → inference) is modular, making it easy to update components or deploy at scale. It can run on-device for privacy or leverage cloud computing for heavier analyses, suitable for both personal use and integration into telehealth platforms.

How It Works (High Level Only)

Our detection workflow is streamlined into four key stages, focusing on high-level functionality without exposing proprietary algorithms:

Pose Estimation: The process begins with a video of the individual performing simple motions (for example, holding their hands out or walking a few steps). An advanced computer vision model analyzes each frame to identify key body landmarks – particularly the hands, arms, and upper body joints. This yields a real-time sequence of coordinates representing the person’s movement (their pose) throughout the video.

Signal Processing: Next, the raw pose data (the movement of key points over time) is filtered and processed to extract meaningful motion signals. We isolate the subtle tremor motion from normal voluntary movement and noise. For instance, if a hand is supposed to be still, the system zooms in on the tiny involuntary oscillations in that hand’s position. This stage may involve smoothing out noise and focusing on the frequency ranges relevant to Parkinson’s tremors.

Tremor Analysis: In this stage, the system quantifies the tremor characteristics. It measures parameters like the frequency of the tremor (how fast the hand or limb is shaking) and the amplitude (how much it moves back and forth). These metrics are critical – Parkinsonian tremors often have distinct frequency profiles and patterns. The system compares the observed motion data against known signatures of Parkinson’s (for example, distinguishing a resting tremor from normal slight jitters or other tremor types). The result is a set of features that describe the person’s movement profile.

Model Inference: Finally, the extracted features are fed into a machine learning model that has been trained on movement data from both Parkinson’s patients (early-stage) and healthy individuals. This model – using high-level pattern recognition – evaluates whether the tremor and movement patterns from the video are indicative of early Parkinson’s disease. The output is an inference or prediction: for example, a risk score or a simple classification (e.g. “Potential Early Parkinson’s Detected” vs “No Parkinson’s Signs”). The system presents this result to the user/clinician along with confidence metrics. Important: This inference is meant as an early screening aid, not a definitive diagnosis – but it provides a crucial alert that can prompt further medical evaluation.

(Throughout this workflow, no proprietary formulas or code are disclosed – the focus is on the conceptual pipeline. The innovation lies in how these pieces are implemented and tuned, which is part of our protected IP.)

Demo Videos

The following demo videos illustrate the system in action. (Video placeholders below – in the actual repository, these would show recorded demos of the working prototype.)

Demo Video 1 – Tremor Detection in Action: A short clip showing a user’s hand stretched out in front of a camera. The system’s interface is visible overlaying the video. As the user tries to keep their hand steady, the AI quickly identifies a subtle tremor, highlighting the trembling motion on-screen (e.g. the hand icon or outline might shake in sync). In real-time, the dashboard graph on the side rises, showing the tremor amplitude, and the system outputs a message indicating a possible early Parkinson’s sign. (Placeholder for actual demo video.)

Demo Video 2 – Full-Body Movement Analysis: This video demonstrates the pose estimation and analysis on a wider scale. The subject is asked to perform a brief walking test or postural holding pose. The system tracks the person’s full-body pose (stick figure skeleton overlaid on the video). Key points like shoulders, elbows, and wrists are monitored. In the demo, you can see real-time joint movement data being plotted. Subtle reductions in one arm’s swing and a slight hand tremor are captured by the system. The output risk assessment updates to reflect these findings, illustrating how the system can detect multiple early motor signs. (Placeholder for actual demo video.)

(Demo videos are for illustrative purposes. They show prototype results and are not diagnostic proof on their own. In the live system, these videos would be replaced with actual recorded demonstrations.)

Screenshots

Below are placeholder screenshots providing a glimpse of the system’s user interface and outputs. These images would be replaced with real screenshots of the application interface.

Screenshot 1 – Detection Dashboard: A snapshot of the main dashboard. In this image, the user’s video feed is on the left, with the pose estimation skeleton drawn on the person. On the right, there’s a live graph displaying the tremor signal waveform (amplitude vs. time), which spikes as a tremor is detected. A prominent indicator on the screen reads something like “Tremor Detected: Yes (Likely Parkinson’s Indicator)” with a confidence percentage. This interface allows users to visually see what the AI is detecting in real time.

Screenshot 2 – System Analysis Report: A static report view generated after a session. This screenshot shows a summary of an analysis – including metrics like “Tremor Frequency: 5.2 Hz”, “Tremor Amplitude: 2 mm”, and a risk score gauge (for example, a dial or progress bar indicating moderate risk). There might also be a comparison chart showing the user’s tremor data versus typical ranges for early Parkinson’s. The layout is clean and informative, suitable for a clinician to review or for a patient to understand the results. Key sections might be highlighted in green/red to indicate normal vs. abnormal findings.

(Please note: The actual screenshots will be added to the repository and may differ in design as the UI is refined.)

Architecture Diagram

(Placeholder for architecture diagram image – a visual overview of the system’s design.)

Imagine a diagram with the following components in sequence, illustrating the end-to-end architecture:

Video Input (camera icon) → Pose Estimation Module (AI model icon) → Signal Processing (filter icon) → Tremor Analysis (graph icon) → ML Inference Model (brain/AI icon) → Output Dashboard (screen icon).

Each block would have brief notes, for example: Pose Estimation uses a neural network to get joint coordinates; Signal Processing filters noise and extracts tremor signal; Tremor Analysis computes features; ML Model outputs prediction; Dashboard displays results to user. Arrows connect the flow, and there might be a feedback loop for continuous monitoring if applicable.

(The actual architecture diagram will be provided as an image in the repository to visually complement the above description.)

Limitations

While our Early Parkinson’s Detection System is a significant step forward, it’s important to understand its current limitations and the context of use:

Not a Formal Diagnosis: This tool is intended for screening and early alert purposes. A positive result does not confirm Parkinson’s disease – it signals that further medical evaluation is warranted. Likewise, a negative result doesn’t absolutely rule out Parkinson’s (especially non-motor-dominant cases). It’s an aid, not a replacement for a neurologist’s assessment.

Early Symptoms Variability: Parkinson’s manifests differently per individual. Our system currently focuses mainly on tremor and overt movement patterns. Some early-stage patients might have minimal tremor but other symptoms (e.g. bradykinesia or rigidity) that are harder to detect via a short video. This means the system could miss cases that don’t exhibit a classic tremor early on (false negatives), or conversely flag tremor that is due to other causes (false positives).

Environmental and Usage Factors: The accuracy of detection can be affected by video quality and how the test is performed. Poor lighting, low-resolution cameras, or significant camera movement can reduce the pose estimation accuracy. We assume the person follows test instructions (e.g. holds still in front of camera for a set duration). In uncontrolled settings, extra noise in movement data might trigger incorrect readings.

Data & Model Bias: The machine learning model’s performance is only as good as the data it was trained on. Currently, our training data for early Parkinson’s tremors is limited (from initial research collaborations and public datasets). This may introduce bias or reduce accuracy for demographic or tremor variations not well-represented in the dataset. We are actively expanding our data coverage, but until then, clinical validation is ongoing and results should be interpreted with caution.

Regulatory Status: As of now, this system is a prototype/PoC (Proof of Concept) and not approved as a medical device. Use of the system in real clinical contexts would require regulatory clearances (e.g. FDA approval) after thorough validation. For the time being, it’s meant for research and demonstration. Users should consent and understand the experimental nature of the results.

In summary, the system is highly promising but not infallible. We are transparent about these limitations and are working to address each through continued development and testing.

Future Scope

We envision a broad and impactful roadmap for this project. Some key directions for future development include:

Wider Symptom Coverage: Expand the system to detect other Parkinson’s symptoms beyond tremor. For example, incorporate gait analysis (monitoring how a person walks for shuffling or imbalance), facial expression analysis (to catch masked facial expressions), or voice analysis (since changes in speech can be early indicators). This would make the tool a more comprehensive Parkinson’s screening suite.

Personalized Monitoring: Evolve the platform into a continuous monitoring tool. Instead of a one-time test, a person at risk could regularly record short videos (or use a smartphone app) and the system would track changes in their movement over months. Subtle trends – like a tremor slowly intensifying over time – could be caught, allowing doctors to intervene earlier in the disease progression.

Improved Accuracy with More Data: We plan to collaborate with healthcare institutions to gather a larger dataset of movement videos from both Parkinson’s patients and healthy controls. More data (with diverse ages, ethnicities, and conditions) will enable us to train more robust models, reduce false alarms, and perhaps even quantify disease severity. Future versions might not just detect Parkinson’s, but also estimate its progression or differentiate it from other movement disorders (like essential tremor).

Real-World Deployments: Work towards deploying the system in real clinical and home settings. This includes developing a mobile app or integration with telemedicine platforms so that users can do a quick Parkinson’s risk check at home and share results with their doctors. On the clinical side, a polished software tool could assist neurologists during check-ups by providing objective movement metrics (as a supplement to their examinations).

Regulatory and Medical Validation: Initiate formal clinical trials and validation studies to prove the system’s efficacy and safety. Our goal is to achieve regulatory approvals (FDA/CE) down the line, which would allow the platform to be used as an approved diagnostic aid. Achieving this would involve rigorous testing, documentation, and likely improving the system’s explainability so clinicians trust its outputs.

Extend to Other Disorders: The core technology – AI pose estimation and motion analysis – can be repurposed to detect or monitor other conditions. In the long term, we could adapt the platform for related neurological disorders (e.g. detecting tremors in essential tremor or movement patterns in Huntington’s disease), or even for tracking rehabilitation progress in stroke patients. This flexibility offers potential new product avenues beyond Parkinson’s.

Our commitment is to continue innovating at the intersection of AI, healthcare, and neurology, transforming what started as a prototype into a fully-fledged tool that makes a real difference in patients’ lives.

Contact & Collaboration

We are actively seeking collaboration, feedback, and partnership opportunities. Whether you are a clinician, researcher, potential investor, or someone passionate about healthcare technology, we’d love to hear from you and explore working together to advance this project.

General Inquiries: For any questions about the project, demonstrations, or discussions about the technology, please reach out via GitHub or through the contact form on the project maintainer’s website. You can open an issue on this repository for public questions, or contact the author directly through Ashraful Momin’s website for private inquiries. (Replace with an email address if appropriate.)

Research & Clinical Partnerships: If you represent a medical research group or a hospital interested in trialing this system or contributing data, we welcome the opportunity. Collaborative studies can help validate the tool in clinical settings. Please get in touch to discuss data sharing and co-development arrangements.

Investment & Support: This project is in an exciting phase and we are open to conversations with investors, accelerators, or healthcare innovation programs that see potential in taking this solution to market. Support in terms of funding, mentorship, or resources could significantly accelerate development towards a deployable product. Please contact us to learn more about our roadmap, business model ideas, and how you could be part of this journey.

Contributing: Given the proprietary nature of the core code (see below), we are not accepting public code contributions at this time. However, we appreciate ideas, suggestions, and feature requests from the community. Feel free to share thoughts via issues or discussions.

We believe that solving hard healthcare challenges requires a community. Let’s collaborate to refine this technology and bring its benefits to those who need it most.

IP + Code Access Disclaimer

Intellectual Property Notice: This repository is provided for demonstration and informational purposes. The core algorithms, model weights, and source code that power the Early Parkinson’s Detection System are proprietary and confidential to the project team. They have been omitted from the public repo to protect intellectual property and pending patent considerations. All rights to the design and methodology are reserved by the creators.

Repository Contents: What you’ll find here is documentation, concept overviews, and media (images/videos) that showcase the system’s capabilities. This allows viewers to understand what the system does and see it in action, without exposing the implementation details. The absence of code is intentional. It reflects our need to safeguard the innovative techniques and ensure responsible use of the technology.

Access to Code: At this time, the project’s codebase is closed-source. We recognize that interested parties (researchers, potential collaborators, etc.) may wish to review or use the code. Such access can be discussed on a case-by-case basis under appropriate non-disclosure agreements (NDAs) or licensing terms. If you have a legitimate interest in the technology (for example, clinical evaluation or integration into a platform), please contact us to discuss possible collaboration or a demonstration. We are open to partnerships that align with our mission, provided they maintain the confidentiality and integrity of the IP.

No Warranty: Given the project’s experimental status, all results and content in this repository are provided “as is” for illustrative purposes. We do not guarantee performance, and the system should not be used for any critical applications without further development and validation. The authors are not liable for any misuse of the information or any actions taken based on the demo results.

By engaging with this project, you acknowledge and respect the above terms regarding intellectual property and code access. We appreciate your interest and understanding. Our ultimate goal is to make this technology available in a responsible way that maximizes benefit to patients while protecting the innovation that underpins it.
